Used as an antitumor agent in cancer research due to its ability to intercalate into DNA and inhibit topoisomerase II, leading to DNA damage and apoptosis in cancer cells. Shows activity against various solid tumors and leukemias in preclinical studies. Investigated for potential use in chemotherapy regimens, particularly where resistance to other DNA-targeting agents is present. Its application remains primarily in experimental and investigational stages, with ongoing studies to improve selectivity and reduce toxicity.